The early impact of medicaid expansion on urologic malignancies in the United States

CONCLUSIONS: Despite increases in the proportion of patients with Medicaid coverage after 2014 in states that enrolled in ME, there was not an associated change in stage at presentation or survival for patients with genitourinary malignancy.PMID:34666919 | DOI:10.1016/j.urolonc.2021.09.002
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Source Type: research